A mutation found in most melanomas rewires cancer cells' metabolism, making them dependent on a ketogenesis enzyme, researchers at Winship Cancer Institute of Emory University have discovered. The finding points to possible strategies for countering resistance to existing drugs that target the B-raf V600E mutation, or potential alternatives to those drugs. It may also explain why the V600E mutation in particular is so common in melanomas.

The growth-promoting V600E mutation in the gene B-raf is present in most melanomas, and also in some cases of colon and thyroid cancer. Drugs such as vemurafenib are available that target this mutation, but in clinical trials, after a period of apparent remission, cancers carrying the V600E mutation invariably develop drug resistance.

Bringing reusable bags to the grocery store brings self-identification as an environmentally friendly shopper, but it also influences the things you buy, according to a new paper in the Journal of Marketing.

Reusable bags were correlated to organic food - no surprise there - but also junk food. 

Think you're a foodie? Adventurous eaters, known as "foodies," are often associated with indulgence and excess. However, a new Cornell Food and Brand Lab study shows just the opposite -adventurous eaters weigh less and may be healthier than their less-adventurous counterparts.

More than 34 million children's lives have been saved since 2000 because of investments in child health programs at a cost of as little as $4,205 per child, according to a new analysis in The Lancet.

This analysis builds off the work of an international collaboration of researchers and, for the first time, creates a scorecard that allows governments, policymakers, and donors to track investments in child health and to link those investments to child deaths averted across countries in a comparable manner.  

A common arthritis drug may also be an effective way to help treat patients with blood cancers—at one thousandth the cost of another drug that works the same way.

Myeloproliferative neoplasms (MPN) cause an overproduction of blood cells resulting in symptoms that include night sweats, itching, and tiredness. MPNs are most often diagnosed in people in their 50s and 60s. Current treatment is limited to aspirin, removal of excess blood, and mild chemotherapy. 

Researchers at the University of Georgia have a message for Southern tree farmers worried about unexplainable pine tree deaths: Don't panic.